Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

USP

This article was originally published in The Tan Sheet

Executive Summary

Industry forum bringing together reps from CHPA, PhRMA, GPhA, NAPM and other drug industry groups to meet with USP once or twice a year to discuss specific issues such as new monograph development and U.S.-EU harmonization. First stakeholder forum for the standards-setting body was Oct. 4, where CHPA and others called for a more transparent monograph process modeled after federal rulemaking. The next two meetings, to be held before June 2001, will involve health care professionals and consumers, respectively, USP says
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

PS091811

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel